Department of Neurology, Yokohama Municipal Citizen's Hospital, Japan.
Intern Med. 2023 Oct 15;62(20):3053-3056. doi: 10.2169/internalmedicine.2339-23. Epub 2023 Aug 2.
A 33-year-old woman developed paresthesia in her right thumb approximately 30 minutes after receiving the BNT162b2 (Pfizer-BioNTech) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. The paresthesia gradually spread to her right-side limbs and trunk, and cervical magnetic resonance imaging (MRI) revealed a localized lesion in the right dorsal column. After glucocorticoid therapy, her symptoms and MRI findings improved. Although disease developing less than 24 hours after vaccination is considered an unlikely cause of immuno-associated adverse events following vaccination, we discuss the possible mechanisms involved in early-onset central nervous system inflammation after vaccination in view of preexisting immunopathological susceptibility.
一位 33 岁女性在接种 BNT162b2(辉瑞-生物科技)严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫苗后约 30 分钟出现右手拇指感觉异常。感觉异常逐渐扩散到右侧肢体和躯干,颈椎磁共振成像(MRI)显示右侧背柱有局灶性病变。糖皮质激素治疗后,她的症状和 MRI 发现均改善。尽管接种疫苗后 24 小时内发病被认为不太可能是接种后免疫相关不良事件的原因,但鉴于预先存在的免疫病理易感性,我们讨论了疫苗接种后早期中枢神经系统炎症的可能涉及的机制。